01 1Merck Sharp & Dohme LLC
01 1IMIPENEM ANHYDROUS, cilastatin, and RELEBACTAM ANHYDROUS
01 1U.S.A
CILASTATIN; IMIPENEM ANHYDROUS; RELEBACTAM ANHYDROUS
NDC Package Code : 0006-0138
Start Marketing Date : 2020-01-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SOLUTION (500mg/100mL 500mg/100mL 250mg/100mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
46
PharmaCompass offers a list of Cilastatin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cilastatin manufacturer or Cilastatin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cilastatin manufacturer or Cilastatin supplier.
PharmaCompass also assists you with knowing the Cilastatin API Price utilized in the formulation of products. Cilastatin API Price is not always fixed or binding as the Cilastatin Price is obtained through a variety of data sources. The Cilastatin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AC-268 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AC-268, including repackagers and relabelers. The FDA regulates AC-268 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AC-268 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of AC-268 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A AC-268 supplier is an individual or a company that provides AC-268 active pharmaceutical ingredient (API) or AC-268 finished formulations upon request. The AC-268 suppliers may include AC-268 API manufacturers, exporters, distributors and traders.
click here to find a list of AC-268 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing AC-268 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for AC-268 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture AC-268 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain AC-268 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a AC-268 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of AC-268 suppliers with NDC on PharmaCompass.
